Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

AIMS: In the randomized, placebo-controlled Colchicine Cardiovascular Outcomes Trial (COLCOT) of 4745 patients enrolled within 30 days after myocardial infarction (MI), low-dose colchicine (0.5 mg once daily) reduced the incidence of the primary composite endpoint of cardiovascular death, resuscitat...

Descripción completa

Detalles Bibliográficos
Autores principales: Samuel, Michelle, Tardif, Jean-Claude, Khairy, Paul, Roubille, François, Waters, David D, Grégoire, Jean C, Pinto, Fausto J, Maggioni, Aldo P, Diaz, Rafael, Berry, Colin, Koenig, Wolfgang, Ostadal, Petr, Lopez-Sendon, Jose, Gamra, Habib, Kiwan, Ghassan S, Dubé, Marie-Pierre, Provencher, Mylène, Orfanos, Andreas, Blondeau, Lucie, Kouz, Simon, L’Allier, Philippe L, Ibrahim, Reda, Bouabdallaoui, Nadia, Mitchell, Dominic, Guertin, Marie-Claude, Lelorier, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445085/
https://www.ncbi.nlm.nih.gov/pubmed/32407460
http://dx.doi.org/10.1093/ehjqcco/qcaa045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445085/
https://www.ncbi.nlm.nih.gov/pubmed/32407460
http://dx.doi.org/10.1093/ehjqcco/qcaa045

Ejemplares similares